Advancis continues to expand patent estate covering antibiotic dosing.(Advancis Pharmaceutical Corp.)
Publication Date: 01-FEB-04
Publication Title: BIOTECH Patent News
Format: Online
Company: Advancis Pharmaceutical Corp.~Intellectual property

Read this article now
Try Goliath Business News - FREE!
You can view this article PLUS...

  • Over 5 million business articles
  • Hundreds of the most trusted magazines, newswires, and journals (see list)
  • Premium business information that is timely and relevant
  • Unlimited Access

Now for a Limited Time, try Goliath Business News
Free for 7 Days!

Tell Me More   Terms and Conditions

Purchase this article for $4.95

Description

Advancis Pharmaceutical Corporation (Germantown, MD) announced that an additional five patents have issued to the company, bringing the company's total patent estate to 21 issued and allowed patents. The new patents allow Advancis to further protect its novel biological finding related to the pulsatile approach to dosing antibiotic and other anti-infective therapies.

On December 16, 2003, Advancis was issued United States Patent 6,663,890 entitled "Metronidazole Antibiotic Product, Use and Formulation Thereof" regarding the pulsatile release dosage...



More articles from BIOTECH Patent News
Isotechnika obtains United States patent.(Brief Article), February 01, 2004
ZymoGenetics obtains United States patent.(Brief Article), February 01, 2004
North Carolina State University obtains United States patent.(Brief Ar..., February 01, 2004
Tokai University obtains United States patent.(Brief Article), February 01, 2004
Boston Medical Center obtains United States patent.(Boston Medical Cen..., February 01, 2004

Looking for additional articles?
Click here to search our database of over 3 million articles.